IL6 and atrial fibrillation: Consistent with our neutrophil-specific gene expression data, Adalimumab decreased LPS-induced increases in the AF levels of IL-6 and other cytokines; chorio-decidua mRNAs expression of cytokines/chemokines; and fetal plasma IL-6 and IL-12p40 levels.